BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38653672)

  • 1. Association of short-chain fatty acids and the gut microbiome with type 2 diabetes: Evidence from the Henan Rural Cohort.
    Yang T; Wu C; Li Y; Wang C; Mao Z; Huo W; Li J; Li Y; Xing W; Li L
    Nutr Metab Cardiovasc Dis; 2024 Jul; 34(7):1619-1630. PubMed ID: 38653672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
    Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
    Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the short-chain fatty acid levels and dietary quality with type 2 diabetes: a case-control study based on Henan Rural Cohort.
    Li J; Li Y; Zhang S; Wang C; Mao Z; Huo W; Yang T; Li Y; Xing W; Li L
    Br J Nutr; 2024 May; 131(10):1668-1677. PubMed ID: 38343180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher Fecal Short-Chain Fatty Acid Levels Are Associated with Gut Microbiome Dysbiosis, Obesity, Hypertension and Cardiometabolic Disease Risk Factors.
    de la Cuesta-Zuluaga J; Mueller NT; Álvarez-Quintero R; Velásquez-Mejía EP; Sierra JA; Corrales-Agudelo V; Carmona JA; Abad JM; Escobar JS
    Nutrients; 2018 Dec; 11(1):. PubMed ID: 30591685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between Diet, the Gut Microbiome, and Short-Chain Fatty Acid Production among Older Caribbean Latino Adults.
    Maldonado-Contreras A; Noel SE; Ward DV; Velez M; Mangano KM
    J Acad Nutr Diet; 2020 Dec; 120(12):2047-2060.e6. PubMed ID: 32798072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Insulin Resistance and Type 2 Diabetes With Gut Microbial Diversity: A Microbiome-Wide Analysis From Population Studies.
    Chen Z; Radjabzadeh D; Chen L; Kurilshikov A; Kavousi M; Ahmadizar F; Ikram MA; Uitterlinden AG; Zhernakova A; Fu J; Kraaij R; Voortman T
    JAMA Netw Open; 2021 Jul; 4(7):e2118811. PubMed ID: 34323983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal Short-Chain Fatty Acids Are Not Predictive of Colonic Tumor Status and Cannot Be Predicted Based on Bacterial Community Structure.
    Sze MA; Topçuoğlu BD; Lesniak NA; Ruffin MT; Schloss PD
    mBio; 2019 Jul; 10(4):. PubMed ID: 31266879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulating the gut microbiota and SCFAs in the faeces of T2DM rats should be one of antidiabetic mechanisms of mogrosides in the fruits of Siraitia grosvenorii.
    Zhang Y; Peng Y; Zhao L; Zhou G; Li X
    J Ethnopharmacol; 2021 Jun; 274():114033. PubMed ID: 33741440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The change of gut microbiota-derived short-chain fatty acids in diabetic kidney disease.
    Zhong C; Dai Z; Chai L; Wu L; Li J; Guo W; Zhang J; Zhang Q; Xue C; Lin H; Luo Q; Cai K
    J Clin Lab Anal; 2021 Dec; 35(12):e24062. PubMed ID: 34689373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications.
    Zhao L; Lou H; Peng Y; Chen S; Zhang Y; Li X
    Endocrine; 2019 Dec; 66(3):526-537. PubMed ID: 31591683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclocarya paliurus polysaccharides alleviate type 2 diabetic symptoms by modulating gut microbiota and short-chain fatty acids.
    Yao Y; Yan L; Chen H; Wu N; Wang W; Wang D
    Phytomedicine; 2020 Oct; 77():153268. PubMed ID: 32663709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained Dysbiosis and Decreased Fecal Short-Chain Fatty Acids after Traumatic Brain Injury and Impact on Neurologic Outcome.
    Opeyemi OM; Rogers MB; Firek BA; Janesko-Feldman K; Vagni V; Mullett SJ; Wendell SG; Nelson BP; New LA; Mariño E; Kochanek PM; Bayır H; Clark RSB; Morowitz MJ; Simon DW
    J Neurotrauma; 2021 Sep; 38(18):2610-2621. PubMed ID: 33957773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease.
    Chen SJ; Chen CC; Liao HY; Lin YT; Wu YW; Liou JM; Wu MS; Kuo CH; Lin CH
    Neurology; 2022 Feb; 98(8):e848-e858. PubMed ID: 34996879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of Dietary Intake with the Intestinal Microbiota and Short-Chain Fatty Acids Among Young Adults with Type 1 Diabetes and Overweight or Obesity.
    Igudesman D; Crandell JL; Corbin KD; Hooper J; Thomas JM; Bulik CM; Pence BW; Pratley RE; Kosorok MR; Maahs DM; Carroll IM; Mayer-Davis EJ
    J Nutr; 2023 Apr; 153(4):1178-1188. PubMed ID: 36841667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Gut Microbiome and Metabolite Characteristics in Patients with Slow Transit Constipation.
    Tian H; Chen Q; Yang B; Qin H; Li N
    Dig Dis Sci; 2021 Sep; 66(9):3026-3035. PubMed ID: 32767153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered gut microbiota and short chain fatty acids in Chinese children with autism spectrum disorder.
    Liu S; Li E; Sun Z; Fu D; Duan G; Jiang M; Yu Y; Mei L; Yang P; Tang Y; Zheng P
    Sci Rep; 2019 Jan; 9(1):287. PubMed ID: 30670726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of complementary feeding is associated with gut microbiota diversity and composition and short chain fatty acid concentrations over the first year of life.
    Differding MK; Benjamin-Neelon SE; Hoyo C; Østbye T; Mueller NT
    BMC Microbiol; 2020 Mar; 20(1):56. PubMed ID: 32160858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Dietary Fibre in Modulating Gut Microbiota Dysbiosis in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
    Ojo O; Feng QQ; Ojo OO; Wang XH
    Nutrients; 2020 Oct; 12(11):. PubMed ID: 33113929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the gut microbiome and fermentation products concurrent with enhanced longevity in acarbose-treated mice.
    Smith BJ; Miller RA; Ericsson AC; Harrison DC; Strong R; Schmidt TM
    BMC Microbiol; 2019 Jun; 19(1):130. PubMed ID: 31195972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential mechanism of Liu-Wei-Di-Huang Pills in treatment of type 2 diabetic mellitus: from gut microbiota to short-chain fatty acids metabolism.
    Yi ZY; Chen L; Wang Y; He D; Zhao D; Zhang SH; Yu R; Huang JH
    Acta Diabetol; 2022 Oct; 59(10):1295-1308. PubMed ID: 35857109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.